To assess the efficacy and safety of combined intravitreal bevacizumab and low-fluency-rate photodynamic therapy (PDT) in the treatment of choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD) and to compare it with intravitreal bevacizumab monotherapy.



Titolo: Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study
Autori: 
TOGNETTO, DANIELE
mostra contributor esterni 
Data di pubblicazione: 2016
Rivista: 
DIGITAL JOURNAL OF OPHTHALMOLOGY  
Abstract: To assess the efficacy and safety of combined intravitreal bevacizumab and low-fluency-rate photodynamic therapy (PDT) in the treatment of choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD) and to compare it with intravitreal bevacizumab monotherapy.
Handle: http://hdl.handle.net/11368/2893645
Digital Object Identifier (DOI): http://dx.doi.org/10.5693/djo.01.2014.01.004
URL: http://www.djo.harvard.edu/site.php?url=/physicians/oa/1803
Appare nelle tipologie:1.1 Articolo in Rivista

File in questo prodotto:
FileDescrizioneTipologiaLicenza 
djo-13-006.pdf Documento in Versione EditorialeDigital Rights Management non definitoAdministrator   Richiedi una copia
Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11368/2893645
  • Citazioni
  • ND

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
 
 
 
©2014 University of Trieste dove siamo Privacy
Piazzale Europa,1 34127 Trieste, Italia - Tel. +39 040.558.7111 - P.IVA 00211830328 - C.F. 80013890324 - P.E.C.: ateneo@pec.units.it
 Copyright © 2020